i.e . asthma ( especially examining the late-phase reaction that involves pmns ) , chronic bronchitis ( in which irritants and bacterial products may stimulate mucus secretion and inflammatory cells ) , interstitial lung diseases ( ipf may disclose pmns but sarcoidosis and hypersensitivity pneumonitis feature collections of activated lymphocytes ) , and acute lung injury leading to adult respiratory distress syndrome ( pmns and their breakdown products and enzymes incite local destruction of alveolar tissue ) .
C0206062
interstitial lung diseases
C0002390
hypersensitivity pneumonitis